COVID-19: Early Vaccine Data; Treatments Investigated; False Negatives With Rapid Test

Inbox

x

MPR Daily Dose <editor@email.empr.com> Unsubscribe

6:56 PM (4 hours ago)

to me

If you are having trouble viewing this email, click here.

TOP TRENDING Early Data Show mRNA Vaccine Against SARS-CoV-2 Elicits Immune Response Immune Globulin Therapy Linked to Heart Function Recovery in COVID-Related Multisystem Inflammatory Syndrome At-Home Use of Inhaled Nitric Oxide for Pulmonary HTN Complicated by COVID-19 Antiviral Merimepodib to Be Investigated in Phase 2 Trial for COVID-19 FDA: False Negatives Possible With Abbott’s Rapid COVID-19 Test Evidence Supporting Use of Compounded Topical Pain Creams Limited Opdivo Plus Yervoy Approved for First-Line Treatment of Metastatic NSCLC Pomalyst Gets Accelerated Approval for Kaposi Sarcoma Long-Acting Injectable Cabotegravir Noninferior to Oral PrEP in HIV Prevention Study REDUCE-IT: Significant Reduction in Coronary Revascularizations With Icosapent Ethyl CME/CE Spotlight Dispelling the Myths of Influenza Management AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists CLICK HERE FOR A FULL LIST OF COURSES CE/CME Powered By myCME